Evove uses nanotechnology and additive manufacturing to develop advanced membrane technology to reduce the impact of water filtration.
Evove has raised $6.9M in total funding. The most recent round was Series A. The last funding was announced in March 2023.
Evove's investors include At One Ventures, AM Ventures.
Evove is headquartered in Daresbury, United Kingdom.
Evove uses nanotechnology and additive manufacturing to develop advanced membrane technology to reduce the impact of water filtration.
Evove is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Evove — Funding & Investors." VCBacked, March 6, 2023, https://www.vcbacked.co/company/evove. Accessed August 14, 2026.
VCBacked. (2023). Evove — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/evove
{{cite web |title=Evove — Funding & Investors |url=https://www.vcbacked.co/company/evove |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated